New to The Street TV Signs 12 Part Media Series, Featuring Innovative MedTech, Inc.
19 août 2024 09h15 HE
|
FMW Media Works Corp
New to The Street TV Signs 12 Part Media Series, Featuring Innovative MedTech, Inc.
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
07 août 2024 07h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDT LYON, France, August 7, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
06 août 2024 07h00 HE
|
EDAP TMS S.A.
Semi-Live Focal One Procedure to be Conducted on August 15th at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
19 juil. 2024 16h15 HE
|
EDAP TMS S.A.
Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in patients with deep infiltrating endometriosisAt...
EDAP Appoints Fran Schulz to Board of Directors
08 juil. 2024 07h00 HE
|
EDAP TMS S.A.
PDF Version LYON, France, July 8, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Fran Schulz to...
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
03 juin 2024 08h00 HE
|
EDAP TMS S.A.
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing disruptive, robotics-based capital equipment in both...
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia (AML)
28 mai 2024 08h00 HE
|
HiberCell, Inc.
HiberCell Announces First Patient Dosed in Phase 1b Clinical Trial in AML, Evaluating HC-7366 in Combination with Venetoclax and Azacitidine
EDAP to Present at the Jefferies Global Healthcare Conference
22 mai 2024 08h00 HE
|
EDAP TMS S.A.
LYON, France, May 22, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled...
EDAP Reports First Quarter 2024 Financial Results
16 mai 2024 08h00 HE
|
EDAP TMS S.A.
Strong Q1 2024 U.S. Focal One® HIFU procedure growth of +92% year-over-year Q1 2024 HIFU revenue of EUR 5.8 million ($6.3 million USD), an increase of 10.2% over Q1 2023Q1 2024 total revenue...
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
13 mai 2024 09h00 HE
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...